Want to see VMD full AI Analyst Report?
VMD Stock Chart & Stats
$9.26
-$0.02(-0.22%)
At close: 4:00 PM EDT
$9.26
-$0.02(-0.22%)
Day’s Range― - ―
52-Week Range$6.05 - $12.61
Previous Close$9.28
Volume155.15K
Average Volume (3M)254.76K
Market Cap
$365.27M
Enterprise Value$471.69M
Total Cash (Recent Filing)$10.68M
Total Debt (Recent Filing)$11.60M
Price to Earnings (P/E)25.1
Beta0.51
Next Earnings
Nov 03, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.38
Shares Outstanding38,088,226
10 Day Avg. Volume233,769
30 Day Avg. Volume254,760
Financial Highlights & Ratios
PEG Ratio0.63
Price to Book (P/B)2.04
Price to Sales (P/S)1.07
P/FCF Ratio24.22
Enterprise Value/Market Cap1.29
Enterprise Value/Revenue1.56
Enterprise Value/Gross Profit2.73
Enterprise Value/Ebitda8.80
Forecast
1Y Price Target
$12.50Price Target Upside34.99% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.41
Revenue Forecast (FY)$318.30M
Bulls Say, Bears Say
Bulls Say
Revenue And Patient GrowthStrong revenue growth alongside a record ventilator patient base indicates expanding demand for Viemed’s home respiratory model. Continued patient additions, improved compliance, and raised full-year guidance support recurring reimbursement revenue and a durable platform for further growth.
Cash Generation And Balance SheetPositive operating cash flow, improving free-cash-flow generation, and a net-cash position give Viemed flexibility to fund expansion, technology investments, and shareholder returns internally. Low leverage also reduces financial risk and preserves capacity to withstand operating variability.
Operational ScalabilityThe Tenor workflow demonstrates that technology can increase patient-processing capacity without a matching increase in fulfillment infrastructure. Faster qualification and scalable operations can support growth, improve execution efficiency, and strengthen Viemed’s competitive position over time.
Bears Say
Margin CompressionLower adjusted EBITDA margins show that rapid growth is not currently translating into equivalent operating leverage. Persistent margin pressure would reduce the cash available for reinvestment and shareholder returns, while making earnings more sensitive to execution and revenue mix.
Lower-Margin Revenue MixA sustained shift from rental revenue toward faster-growing product and service activity could structurally lower consolidated profitability. Although the newer mix is less capital-intensive, Viemed may need stronger scale and efficiency gains to offset its lower adjusted EBITDA margins.
Respiratory Therapist CapacityUncertainty about patient-per-therapist productivity creates a capacity risk for Viemed’s clinical model. If compliance and education requirements require more hiring, labor costs could rise, operating leverage could weaken, and patient growth could become more resource-intensive.
Viemed Healthcare News
VMD FAQ
What was Viemed Healthcare Inc’s price range in the past 12 months?
Viemed Healthcare Inc lowest stock price was $6.05 and its highest was $12.61 in the past 12 months.
What is Viemed Healthcare Inc’s market cap?
Viemed Healthcare Inc’s market cap is $365.27M.
When is Viemed Healthcare Inc’s upcoming earnings report date?
Viemed Healthcare Inc’s upcoming earnings report date is Nov 03, 2026 which is in 14 days.
How were Viemed Healthcare Inc’s earnings last quarter?
Viemed Healthcare Inc released its earnings results on Aug 03, 2026. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.12 by -$0.05.
Is Viemed Healthcare Inc overvalued?
According to Wall Street analysts Viemed Healthcare Inc’s price is currently Undervalued.
Does Viemed Healthcare Inc pay dividends?
Viemed Healthcare Inc does not currently pay dividends.
What is Viemed Healthcare Inc’s EPS estimate?
Viemed Healthcare Inc’s EPS estimate is 0.12.
How many shares outstanding does Viemed Healthcare Inc have?
Viemed Healthcare Inc has 38,088,226 shares outstanding.
What happened to Viemed Healthcare Inc’s price movement after its last earnings report?
Viemed Healthcare Inc reported an EPS of $0.07 in its last earnings report, missing expectations of $0.12. Following the earnings report the stock price went down -15.868%.
Which hedge fund is a major shareholder of Viemed Healthcare Inc?
Currently, no hedge funds are holding shares in VMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Viemed Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.50 (34.99% Upside)
$12.50 (34.99% Upside)
Blogger Sentiment
Bullish
VMD Sentiment 60%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 4.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
43.99%
12-Months-Change
Fundamentals
Return on Equity
10.30%
Trailing 12-Months
Asset Growth
10.63%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Viemed Healthcare Inc
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
VMD Company Deck
VMD Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple material operational and financial positives: record revenue, the largest-ever active ventilator patient base, strong sequential and year-over-year growth in sleep and resupply, improving compliance, improved cash generation, and clear investments in technology and scalability (e.g., Tenor). Offsetting these were margin pressures in adjusted EBITDA and gross margin driven by revenue mix shifts, temporary maternal health transition costs, higher SG&A from deliberate scaling and one-time duplicative costs, and some near-term uncertainty on RT capacity. Management communicated confidence in the growth trajectory, provided constructive explanations for margin dynamics, and raised revenue guidance while outlining levers for second-half operating leverage.View all VMD earnings summariesVMD Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$12.50
▲(34.99% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
13.93% Insiders
13.16% Mutual Funds
1.04% Other Institutional Investors
62.63% Public Companies and
Individual Investors










